Expression of CD44 variant 6 and its prognostic value in benign and malignant endometrial tissue

ÇELİK H., Gungor M., Ortac F., Kankaya D., ENSARİ A.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS, vol.296, no.2, pp.313-318, 2017 (SCI-Expanded) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 296 Issue: 2
  • Publication Date: 2017
  • Doi Number: 10.1007/s00404-017-4430-9
  • Journal Name: ARCHIVES OF GYNECOLOGY AND OBSTETRICS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.313-318
  • Keywords: CD44v6 expression, Endometrial cancer, Immunohistochemistry, Prognostic factors, CLINICOPATHOLOGICAL SIGNIFICANCE, GENE-EXPRESSION, MENSTRUAL-CYCLE, SPLICE VARIANTS, CERVICAL-CANCER, OVARIAN-CANCER, MESSENGER-RNA, CARCINOMA, ISOFORMS, ASSOCIATION
  • Acibadem Mehmet Ali Aydinlar University Affiliated: No

Abstract

CD44 expression in both the early and metastatic phases of many epithelial and non-epithelial cancers is strongly prognostic. The objective of the study is to evaluate whether there is any relationship between the expression of CDD44v6 and endometrial cancer (EC) staging and prognosis.